Study of a Nutritional Supplement for Healthy Aging
ACTIPRO SENIOR
Study of the Efficacy of a New Nutritional Supplement, Compared with Placebo, in Promoting Active and Healthy Aging from the Age of 65
1 other identifier
interventional
60
1 country
1
Brief Summary
The main aim of this clinical trial is to learn if a nutritional supplement improves health status from a nutritional point of view in an active and healthy elderly population. It will also study about the improvement of anthropometric variables, vitality, quality of life and mood, as well as biochemical and metabolic changes produced after the intervention. The main questions it aims to answer are:
- Does a nutritional supplement improve the general nutritional status?
- What health parameters improve most clearly after taking the supplement? Researchers will compare a nutritional supplement to a placebo (a look-alike substance that contains no interest nutrients) to see if the nutritional supplement works to improve health status from a nutritional point of view. Participants will:
- Take a nutritional supplement or a placebo every day for 8 weeks.
- Visit the clinic once every 4 weeks for checkups and tests
- Keep a diary of their symptoms and the degree of adherence to taking the nutritional supplement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedFirst Submitted
Initial submission to the registry
December 16, 2024
CompletedFirst Posted
Study publicly available on registry
December 20, 2024
CompletedDecember 20, 2024
December 1, 2024
7 months
December 16, 2024
December 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nutritional score.
A nutritional score was created ad hoc to estimate the effects of a nutritional supplement . The parameters included in the score were: muscle mass, lymphocyte level, protein status, vitamin D, folic acid, vitamin B12, calcium, iron, zinc, and homocysteine levels
Days 0 and 56
Secondary Outcomes (24)
Dietary intake
Days 0 and 56
Height
Days 0 and 56
Weight
Days 0 and 56
Waist circumference
Days 0 and 56
Hip circumference
Days 0 and 56
- +19 more secondary outcomes
Study Arms (2)
Nutritional Supplement
EXPERIMENTAL1 sachet of nutritional supplement (30g) in the morning and 1 sachet (30g) in the afternoon during 8 weeks. A total of 60g daily.
Control
PLACEBO COMPARATOR1 sachet of placebo supplement (30g) in the morning and 1 sachet (30g) in the afternoon during 8 weeks. A total of 60g daily.
Interventions
60g of a nutritional supplement powder, divided into 2 daily intakes, one in the morning and one in the afternoon
60g of a placebo supplement powder, divided into 2 daily intakes, one in the morning and one in the afternoon
Eligibility Criteria
You may qualify if:
- Men and women between 65 and 80 years of age, inclusive.
- Body mass index (BMI) less than 35 kg/m2.
- Subjects must have a cultural level, general physical and psychological conditions that allow the understanding, monitoring and development of the study.
- Agree to voluntarily participate in the study and provide their informed consent in writing, complying with the procedures and requirements of the study.
You may not qualify if:
- People allergic to soy or lactose, as the supplement contains traces.
- Severe diseases or relevant functional or structural abnormalities of the digestive system: inflammatory bowel disease.
- Surgical interventions of the digestive system with permanent sequelae such as resections (gastroduodenostomy…)
- Presenting any type of serious or chronic or systemic disease such as: infections that cause impairment of the general condition, cardiovascular diseases, cardiac arrhythmias, stroke, neoplasia, severe kidney disease, liver disease…
- Recent fracture in the last 3 months (strength training).
- Subjects who present some type of cognitive and/or psychological impediment, Alzheimer's, depressive pathology, etc.
- Pharmacological treatment that affects the study variables recently prescribed, without a stable dose prescribed.
- People with diabetes of any type.
- Intake of any type of nutritional supplement that includes vitamin D, folic acid, vitamin B6, vitamin B12, calcium, iron, zinc or proteins, in the last 3 months.
- Being on any type of special diet and/or high alcohol consumption (more than 14 units in women and 20 units in men per week).
- Subjects in whom poor collaboration is expected or who, in the opinion of the researcher, have difficulties in following the procedures of the study.
- Lack of commitment (in the opinion of the researcher) to the intervention, suspicion of non-compliance, or real difficulties in following the development of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Navarra
Pamplona, Navarre, 31008, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2024
First Posted
December 20, 2024
Study Start
September 1, 2021
Primary Completion
April 4, 2022
Study Completion
September 30, 2022
Last Updated
December 20, 2024
Record last verified: 2024-12